Results 281 to 290 of about 1,815,249 (352)
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech +4 more
wiley +1 more source
Virtual Reality Exposure Therapy for Reducing School Anxiety in Adolescents: Pilot Study.
Beele G +8 more
europepmc +1 more source
A systematic review of written exposure therapy for the treatment of posttraumatic stress symptoms. [PDF]
DeJesus CR, Trendel SL, Sloan DM.
europepmc +1 more source
Objective We aimed to test the efficacy of personalized treatment of older Veterans with chronic low back pain (CLBP) delivered by Aging Back Clinics (ABC) as compared with usual care (UC). Methods Two hundred ninety‐nine Veterans age 65‐89 with CLBP from 3 VA medical centers underwent baseline testing, randomization to ABC or UC and 12 months follow ...
Debra K. Weiner +9 more
wiley +1 more source
Exploring cardiac-related PTSD symptoms in patients with implantable cardioverter defibrillators: protocol for an open-label trial of written exposure therapy and qualitative study. [PDF]
Meinhausen C, Ajijola OA, Sumner JA.
europepmc +1 more source
Therapist perspectives on telehealth-based virtual reality exposure therapy. [PDF]
Ong T +7 more
europepmc +1 more source
Ketamine-enhanced prolonged exposure therapy in veterans with PTSD: A randomized controlled trial protocol. [PDF]
Shiroma PR +14 more
europepmc +1 more source

